Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6881208 | THE MEDICINES CO | Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
Apr, 2022
(1 year, 5 months ago) | |
US6975902 | THE MEDICINES CO | Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof |
Apr, 2024
(5 months from now) | |
US8301238 | THE MEDICINES CO | Two-part electrotransport device |
Sep, 2031
(7 years from now) | |
US9364656 | THE MEDICINES CO | Method of storing an electrotransport drug delivery device |
Sep, 2031
(7 years from now) | |
US9731121 | THE MEDICINES CO | Switch validation circuit and method |
Oct, 2031
(8 years from now) | |
US8781571 | THE MEDICINES CO | Switch validation circuit and method |
Mar, 2032
(8 years from now) | |
US8428708 | THE MEDICINES CO | Self-test for analgesic product |
May, 2032
(8 years from now) | |
US8428709 | THE MEDICINES CO | Current control for electrotransport drug delivery |
Jun, 2032
(8 years from now) | |
US9095706 | THE MEDICINES CO | Self-test for analgesic product |
Feb, 2033
(9 years from now) |
Drugs and Companies using FENTANYL HYDROCHLORIDE ingredient
Market Authorisation Date: 22 May, 2006
Treatment: Method for iontophoretic transdermal delivery of fentanyl hydrochloride
Dosage: SYSTEM;IONTOPHORESIS, TRANSDERMAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic